Immunomedics (IMMU)

21.52 -1.01 (4.48%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/8/18 *Est.)

Latest Headlines

Form 4 IMMUNOMEDICS INC For: Apr 02 Filed by: Islam Khalid September 19, 2018 3:22 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Apr 02 Filed by: venBio Select Advisor LLC September 18, 2018 5:21 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 14 Filed by: Fricker William September 18, 2018 3:43 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 14 Filed by: Delaney Brendan September 18, 2018 3:42 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 14 Filed by: Malik Usama September 18, 2018 3:12 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 14 Filed by: Iannone Robert September 18, 2018 3:07 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Apr 02 Filed by: Canute Scott A September 18, 2018 3:00 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Apr 02 Filed by: HUTT PETER BARTON September 18, 2018 2:56 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 14 Filed by: PEHL MICHAEL F. September 18, 2018 2:52 PM - SEC Filing Form 4 IMMUNOMEDICS INC For: Sep 14 Filed by: ROSENBERG MORRIS September 18, 2018 2:49 PM - SEC Filing Guggenheim Starts Immunomedics (IMMU) at Buy September 17, 2018 4:31 PM - StreetInsider Goldman Sachs Starts Immunomedics (IMMU) at Buy September 17, 2018 5:15 AM - StreetInsider Form 8-K IMMUNOMEDICS INC For: Sep 11 September 12, 2018 8:16 AM - SEC Filing Immunomedics (IMMU), Samsung BioLogics Announce Strategic Manufacturing Partnership September 12, 2018 8:00 AM - StreetInsider Immunomedics and Samsung BioLogics Announce Strategic Manufacturing Partnership September 12, 2018 8:00 AM - Globe NewsWire Immunomedics and Samsung BioLogics Announce Strategic Manufacturing Partnership September 12, 2018 8:00 AM - StreetInsider Form 3 IMMUNOMEDICS INC For: Aug 23 Filed by: Fricker William September 7, 2018 5:01 PM - SEC Filing Immunomedics Announces Participation in Upcoming Healthcare Conferences August 28, 2018 8:00 AM - Globe NewsWire Immunomedics Announces Participation in Upcoming Healthcare Conferences August 28, 2018 8:00 AM - StreetInsider Form 10-K/A IMMUNOMEDICS INC For: Jun 30 August 24, 2018 5:08 PM - SEC Filing Immunomedics (IMMU) PT Raised to $55 at B.Riley/FBR August 24, 2018 9:31 AM - StreetInsider Form 8-K IMMUNOMEDICS INC For: Aug 23 August 23, 2018 4:22 PM - SEC Filing Immunomedics (IMMU) Misses Q4 EPS by 46c August 23, 2018 4:10 PM - StreetInsider Form 10-K IMMUNOMEDICS INC For: Jun 30 August 23, 2018 4:10 PM - SEC Filing Form 8-K IMMUNOMEDICS INC For: Aug 23 August 23, 2018 4:02 PM - SEC Filing Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update August 23, 2018 4:00 PM - Globe NewsWire Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update August 23, 2018 4:00 PM - StreetInsider Immunomedics to Report Fourth Quarter and Fiscal Year 2018 Results and Host Conference Call and Webcast on August 23, 2018 August 16, 2018 4:35 PM - Globe NewsWire Immunomedics to Report Fourth Quarter and Fiscal Year 2018 Results and Host Conference Call and Webcast on August 23, 2018 August 16, 2018 4:35 PM - StreetInsider Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions July 30, 2018 8:00 AM - Globe NewsWire Immunomedics Announces Multiple Clinical and Preclinical Collaborations With Prominent Cancer Research Institutions July 30, 2018 8:00 AM - StreetInsider Immunomedics (IMMU) Reports Clinical Collaboration With AstraZeneca (AZN) in First-Line Triple-Negative Breast and Urothelial Cancers July 23, 2018 8:07 AM - StreetInsider Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers July 23, 2018 8:00 AM - Globe NewsWire Immunomedics Announces Clinical Collaboration With AstraZeneca in First-Line Triple-Negative Breast and Urothelial Cancers July 23, 2018 8:00 AM - StreetInsider Form 8-K IMMUNOMEDICS INC For: Jul 18 July 18, 2018 8:16 AM - SEC Filing Immunomedics (IMMU) Reports FDA Acceptance of Biologics License Application for Filing and Granted Priority Review for Sacituzumab Govitecan July 18, 2018 8:03 AM - StreetInsider FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer July 18, 2018 8:00 AM - Globe NewsWire FDA Accepts Biologics License Application for Filing and Grants Priority Review for Sacituzumab Govitecan for the Treatment of Metastatic Triple-negative Breast Cancer July 18, 2018 8:00 AM - StreetInsider Form 8-K IMMUNOMEDICS INC For: Jul 06 July 12, 2018 4:31 PM - SEC Filing Immunomedics (IMMU) PT Raised to $30 at Jefferies July 9, 2018 8:27 AM - StreetInsider Full Article List